INTRODUCTION
Alzheimer's disease (AD) is a chronic, neurodegenerative disorder characterized by progressive dementia [1, 2] . AD will become a serious problem in an aging society because it usually occurs in the elderly. Therefore, research into its causes and practical treatments is becoming necessary. Many factors are involved in AD including aberrant protein processing, genetic effects, oxida-tive stress, cholinergic deficiency, inflammation and excitotoxicity. However, definitive AD therapies and diagnosis remain uncertain [3, 4] . One of the most promising approaches for AD treatment is acetylcholinesterase (AChE) inhibition, which can reduce acetylcholine levels in the brain [5] . There are only a few drugs that are approved by the Food and Drug Administration (FDA) for AChE inhibition, including tacrine, donepezil, rivastigmine and galantamine [6] . Thus, the search for new AChE inhibitors is highly necessary to broaden the selection of drugs available to treat AD. The modern pharmaceutical field has focused its attention on natural products that have been used for centuries throughout the world. Thus, research on discovering new AChE inhibitors has been focused on compounds derived from natural sources.
Citrus unshiu Markovich (Rutaceae), also known as the satsuma mandarin, is cultivated in countries in cool subtropical regions including Korea, and is consumed in a variety of forms such as fresh juice, citrus-based drinks, jam, salad dressing and tea [7, 8] . Due to its sweet and fresh flavor, it is one of the most popular fruits in Korea. In addition, for centuries it has been consumed not only as food but also as a medicine. The peel of C. unshiu, well-known as "Jin-pee", has been used for traditional herbal medicines against the common cold, exhaustion and cancer [7, 9] . Previous studies have demonstrated that the peel has antitumor properties in a tumor-bearing murine model [9] as well as antioxidant activity [1012] . The peel contains compounds associated with antioxidant and free radical scavenging effects such as ascorbic acid, flavonoids and phenolic compounds. In particular, phenolic compounds from the peel including flavonoids and hydroxyl cinnamic acids have a number of biological and pharmacological effects including anti-inflammatory, antimicrobial, antithrombotic, antiallergenic, cardioprotective and vasodilatory effects, along with hypocholesterolemic, hypoglycemic and antitumor activity [11, 12] .
In our ongoing search for bioactive constituents from Korean natural resources, we have investigated bioactive compounds from the fruit of C. unshiu. In our recent studies, we reported the isolation of a novel cyclic peptide, citrusin XI, and its anti-inflammatory effects in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells [13] . In addition, we discovered a new flavonoid glycoside, limocitrunshin, together with other flavonoids, and evaluated their inhibitory effects on renal cell damage and nitric oxide (NO) production [7] . NO is an important pro-inflammatory mediator that can accelerate the appearance of some neurodegenerative disorders such as AD [14] . Thus, the fruit of C. unshiu containing compounds with NO inhibitory properties may be a promising candidate for providing therapeutic agents for AD. In our continued interest in discovering bioactive compounds of C. unshiu fruit, we further investigated such for possible new natural AChE inhibitors from the fruit of C. unshiu. Nine compounds designated as 1-9 including a limonoid and eight flavonoids were isolated, and the inhibitory effects of the isolates on AChE activity were evaluated using a micro-well plate AChE inhibition assay.
EXPERIMENTAL

General experimental procedures
Optical rotations were measured on a Jasco P-1020 polarimeter (Jasco, Easton, MD, USA). Infrared (IR) spectra were recorded on a Bruker IFS-66/S FT-IR spectrometer (Bruker, Karlsruhe, Germany). Ultraviolet (UV) spectra were acquired on an Agilent 8453 UV-visible spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). High-resolution (HR)-electrospray ionization (ESI) mass spectra were recorded on a Waters UPLC-QTOF Xevo G2-S mass spectrometer (Waters Corporation, Milford, CT, USA). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AVANCE III 700 NMR spectrometer operating at 700 MHz ( 1 H) and 175 MHz ( 13 C), with chemical shifts given in ppm (δ) (Bruker). Preparative high-performance liquid chromatography (HPLC) purification was carried out on an Agilent 1100 or 1200 Series HPLC system (Agilent Technologies) equipped with a photo diode array detector. LC-MS analysis was performed on an Agilent 1200 Series HPLC system equipped with a diode array detector and a 6130 Series ESI mass spectrometer using an analytical Kinetex ® 5 µm C18 100 Å column (5 μm, 2.1 × 100 mm, Phenomenex, Torrance, CA, USA). Column chromatography was performed with a silica gel 60 (Merck, Darmstadt, Germany; 230-400 mesh) and an RP-C 18 silica gel (Merck, 230-400 mesh). The packing material for molecular sieve column chromatography was Sephadex LH-20 (Pharmacia, Uppsala, Sweden). Merck precoated silica gel F 254 plates and reversephase (RP)-18 F 254s plates (Merck) were used for thin-layer chromatography (TLC). Spots were detected on TLC under UV light or by heating after spraying with anisaldehyde-sulfuric acid.
Plant material
Fully ripe fruit of the "Miyagawa-wase" variety of satsuma mandarin (C. unshiu Marc.) were obtained from the National Institutes of Horticultural and Herbal Science, Jeju, Korea, in August 2012. Plant material was identified by one of the authors (K. H. Kim). A voucher specimen (SKKU-CU 2012-8) has been stored in the herbarium of the School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Extraction and isolation
The unpeeled fruit of C. unshiu (1.0 kg) was extracted twice with 100% EtOH (2 × 2 days) at room temperature. The resultant extract was then filtered and concentrated under vacuum pressure to yield crude extracts. EtOH extracts (89.0 g) were suspended in distilled water (10 liters) and successively partitioned with hexane, EtOAc and nBuOH, yielding residues weighing 230 mg, 3.0 g and 15.0 g, respectively. The EtOAc-soluble fraction (3.0 g) was subjected to fractionation with silica gel column chromatography using a gradient solvent system of n-hexane-EtOAc (1 : 1), CHCl 3 -MeOH (50 : 1, 10 : 1, 5 : 1, 2 : 1 and 1 : 1) and 100% MeOH to give thirty fractions (E1-E30) according to TLC analysis. Fraction E7 (260 mg) was applied to column chromatography on an RP-C 18 silica gel column using a solvent system of MeOH-H 2 O (2 : 1) to yield 10 sub-fractions (E7a-E7j). Fraction E7b (52 mg) was further purified by semipreparative RP HPLC (250 mm × 10 mm i.d., 10 μm, Phenomenex Luna C18(2) column, flow rate 1.5 ml/min) using a solvent system of MeOH-H 2 O (2 : 1) to afford compounds 1 (8.0 mg), 3 (12.0 mg) and 5 (6.4 mg). The n-BuOH soluble fraction (15.0 g) was subjected to fractionation with HP-20 column chromatography using a gradient solvent system that increased MeOH in H 2 O from 0% to 100% to yield six fractions (B1-B6) according to TLC analysis. Fraction B2 (4.5 g) was further subjected to silica gel column chromatography using a solvent system of CHCl 3 -MeOH-H 2 O (7 : 3 : 1) to obtain 32 sub-fractions (B2(1)-B2(32)). Fraction B2(11) (122 mg) was purified by preparative RP HPLC (250 mm × 20 mm i.d., 10 μm, YMC-Pack ODS-AM C18(2) column, flow rate 8.0 ml/min) using a 40% MeOH solvent system to obtain compound 9 (38.0 mg). Fraction B2(31) (277 mg) was further separated by preparative RP HPLC (250 mm × 20 mm i.d., 10 μm, YMC-Pack ODS-AM C18(2) column, flow rate 10.0 ml/min) using a 40% MeOH solvent system to yield compound 6 (9.0 mg), along with subfraction B2(31)A (87.0 mg), which was further purified by semipreparative RP HPLC (250 mm × 10 mm i.d., 10 μm, Phenomenex Luna C18(2) column, flow rate 2.0 ml/min) with a 30% MeOH solvent system to furnish compound 8 (30.0 mg). Fraction B4 (2.8 g) was applied to a silica gel column using a gradient of CHCl 3 -MeOH-H 2 O (8 : 3 : 1, 6 : 3 : 1 and 6 : 4 : 1) and 100% MeOH to give 29 sub-fractions (B4(1)-B4 (29)). Fraction B4(9) (44 mg) was purified by semi-preparative RP HPLC (250 mm × 10 mm i.d., 10 μm, Phenomenex Luna C18(2) column, flow rate 2.0 ml/min) using a 40% MeOH solvent system to afford compound 7 (5.2 mg). Fraction B4(15) (168 mg) was further separated by semipreparative RP HPLC (250 mm × 10 mm i.d., 10 μm, Phenomenex Luna C18(2) column, flow rate 2.0 ml/min) with a 40% MeOH solvent system to yield compound 2 (21.5 mg). Finally, fraction B6 (3.2 g) was subjected to silica gel column chromatography using a gradient of CHCl 3 -MeOH-H 2 O (8 : 3 : 1) and 100% MeOH to give 20 sub-fractions (B6(1)-B6 (20)). Fraction B6(10) (383 mg) was purified by semi-preparative RP HPLC (250 mm × 10 mm i.d., 10 μm, Phenomenex Luna C18(2) column, flow rate 3.0 ml/min) using a 40% MeOH solvent system to obtain compound 4 (6.0 mg). 
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AChE inhibition activity
An Acetylcholinesterase Activity Colorimetric Assay Kit was purchased from BioVision (Milpitas, CA, USA) and AChE inhibition activity was measured using the AChE assay kit according to the manufacturer's protocol. In brief, 50 µl of sample (30 μg/ml) and assay buffer was added to each well in a 96-well plate, followed by the addition of 50 µl of the reaction mixture. After incubation at 37 °C for 20 min, absorbance at 570 nm was measured using a microplate reader (PowerWave XS; Bio-Tek Instruments, Winooski, VT, USA). Aricept (10 μM) was used as a positive control.
Statistical analysis
Statistical significance was determined with analysis of variance (ANOVA) followed by a multiple comparison test with Bonferroni adjustment. P values less than 0.05 were considered statistically significant. Analyses were performed using SPSS version 19.0 (SPSS Inc., Chicago, IL, USA).
RESULTS AND DISCUSSION
Isolation and structural elucidation of compounds
The unpeeled C. unshiu fruit was extracted with 100% EtOH to give crude EtOH extracts (89.0 g) that were solvent-partitioned with hexane, EtOAc and n-BuOH. Phytochemical investigation of the EtOAc and n-BuOH soluble fractions using repeated column chromatography and HPLC purification resulted in isolation and identification of nine compounds, 1-9 (Fig. 1) . The compounds were identified as methyl nomilinate (1) [15] , limocitrunshin (2) [7] , nobiletin (3) [16] , kaempferol 3-O-rutinoside (4) [17] , limocitrin 3-glucoside (5) [18] , kaempferol 3-(2 G -rhamnosylrutinoside) (6) [17] , didymin (7) [19] , (2S)-narirutin 4'-Oglucoside (8) [20] and naringenin 7-O-rutinoside (9) [21] , respectively, based on comparison of their spectroscopic and physical data with those previously reported as well as by measurement of their specific rotations.
Evaluation of AChE inhibition activity of the isolates
Compounds 1-9 were evaluated for inhibitory effects on AChE to verify their potential health benefits. The inhibition effects of compounds 1-9 on AChE activity were examined using a microwell plate AChE inhibition assay [22] . Fifty µl of sample (30 μg/ml) and assay buffer was added to each well of a 96-well plate, followed by the addition of 50 µl of the reaction mixture. After incubation at 37 °C for 20 min, the absorbance at 570 nm was measured using a microplate reader. Aricept (10 μM) was used as a positive control.
Inhibition of AChE activity leading to an increase in acetylcholine concentration in the brain is recognized as a potential treatment for mild to moderate AD and various other memory impairment disorders [2327] . At a concentration of 30 μg/ml, compound 1 inhibited AChE activity by more than 50% (Fig. 2) . Compared with the control, compound 1 showed a 44.11  1.1% AChE inhibition. This effect was similar to the 34.40  1.2% inhibition seen with a 10 μM concentration of Aricept (positive control). However, the other compounds showed weak (compounds 4, 5, 6 and 8) to no inhibition (compounds 2, 3, 7 and 9) of AChE activity when compared to the control (Table 1) .
T a b l e 1
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Limonoid as a potential AChE activity inhibitor
In the micro-well plate AChE inhibition assay of compounds 1-9, compound 1 was the most potent AChE activity inhibitor. Compound 1 is a highly oxygenated limonoid compound with a prototypical structure consisting of four six-membered rings and a furan ring. This type of limonoid compound is abundant in citrus fruit and other plants from the families Rutaceae and Meliaceae [14] . Limonoids have been reported to exhibit diverse bioactivity including insecticidal, antibacterial, antifungal, antiviral and anticancer effects [28] . There have been widespread efforts to identify new AChE inhibitors from natural sources, but only limited work has focused on limonoids. Recently, three limonoids isolated from Trichilia welwitschii were reported to show weak to moderate inhibitory effects on AChE activity [14, 29] . Our present findings suggest for the first time that another limonoid, methyl nomilinate (1), is a potential AChE activity inhibitor.
In our previous study, we found that methyl nomilinate showed an anti-inflammatory effect by inhibiting NO production by LPS-activated RAW 264.7 macrophages and significantly abrogated cisplatin-induced nephrotoxicity in LLC-PK1 cells [7] . In addition, methyl nomilinate was reported to inhibit the proliferation of MCF-7 ER+ human breast cancer cells with an IC 50 of 0.01 μg/ml [30] . Recently, methyl nomilinate from citrus was shown to inhibit cell proliferation in the SW480 human colon cancer cell line through the modulation of G1 cell cycle regulators [31] .
CONCLUSION
Phytochemical investigation of the EtOH extract of C. unshiu fruit led to the isolation and identification of nine compounds including one limonoid and eight flavonoids. AChE inhibition has been considered one of the promising temporary treatments for AD. The inhibitory effect of these isolates on AChE activity was evaluated using a micro-well plate AChE inhibition assay, which indicated that the limonoid, methyl nomilinate (1), exhibited significant AChE inhibitory activity. This is the first study to identify the limonoid methyl nomilinate from C. unshiu fruit as a natural AChE inhibitor. Additionally, our findings suggest that C. unshiu fruit, one of the most popular fruits in Korea, can serve as a valuable natural, functional food source of therapeutic agents for AD.
